Stock kasuwa, musayar ciniki a yau
Rahoton samfurori na kamfanonin 71229 a ainihin lokacin.
Stock kasuwa, musayar ciniki a yau

Rahoton samfurori

Stock ya faɗi a kan layi

Stock ya faɗi tarihi

Kasashen kasuwancin jari

Stock dividends

Riba daga kamfanin kamfanoni

Rahotan kuɗi

Ƙididdiga na kamfanoni. A ina zan zuba kudi?

Mersana Therapeutics, Inc. kasuwar kasuwa

Matsayin kasuwancin jari na Mersana Therapeutics, Inc. a yau da kuma tarihin ƙaddamar da Mersana Therapeutics, Inc. daga farkon kasuwanci a MRSN hannun jari akan musayar jari.
Ƙara zuwa widget din
Ƙara zuwa widget din

Mersana Therapeutics, Inc. girma

Yau kasuwa kasuwa na Mersana Therapeutics, Inc. shine 731 307 648 US dollar.
+32 175 360 $ (+4.60%)
canji na strongn kudi tun jiya

Mersana Therapeutics, Inc. ikon mallaka a daloli a yau. Canji a cikin kasuwancin Mersana Therapeutics, Inc. shafin yanar gizon mu yana karɓar sau ɗaya a rana. Mersana Therapeutics, Inc. taken capitalization na yau akan rukunin yanar gizon mu don tunani. Mersana Therapeutics, Inc. karfafan haɓaka ya karu da $ 32 175 360.

Mersana Therapeutics, Inc. girma na kasuwanci

Yau yaudarar kasuwancin jari Mersana Therapeutics, Inc. ya kai 858 932 US dollar.
-13 738 144 $ (-94.12%)
canjin karuwar kasuwancin tun jiya

Mersana Therapeutics, Inc. girman ciniki yau - 858 932 dalar Amurka. Mersana Therapeutics, Inc. an gabatar da ginshiƙi mai ciniki a shafin yau da kullun. Mersana Therapeutics, Inc. ciniki wanda aka gudanar kan musayar bayanan hannun jari a ainihin lokacin, muna nuna ƙimar ciniki ta yau da kullun Mersana Therapeutics, Inc.. Mersana Therapeutics, Inc. karuwanci yana girma kowace rana a dalar Amurka.

Nuna:
To

Mersana Therapeutics, Inc. kasuwar kasuwa

Mersana Therapeutics, Inc. ginshiƙi na kasuwar kwastomomi cikin shekaru. 73.14% - wani canji a cikin kasuwar kasuwar Mersana Therapeutics, Inc. a mako guda. Mersana Therapeutics, Inc. canjin tsarin sarauta na shekara shine 0%. A yau, ana ƙididdigar harajin Mersana Therapeutics, Inc. a 731 307 648 dalar Amurka.

Week Watan 3 months Shekara 3 shekaru

Mersana Therapeutics, Inc. tarihin lalata

Kwanan Girma
Babban jari (kasuwannin kasuwa) shine kasuwa na kasuwa na kamfanonin da ke sayarwa akan musayar jari. Mahimmancin kasuwancin yana daidai da farashin hannun jari da yawa ta hanyar yawan kuɗi.
04/05/2023 731 307 648 $
03/05/2023 699 132 288 $
02/05/2023 471 341 664 $
01/05/2023 508 802 464 $
28/04/2023 469 913 088 $
27/04/2023 413 199 456 $
26/04/2023 422 381 664 $

Mersana Therapeutics, Inc. tashar girma

Week Watan 3 months Shekara 3 shekaru

Mersana Therapeutics, Inc. bayanan tarihi na tarihi

Kwanan Volume (24h)
Ƙaramar kasuwancin Mersana Therapeutics, Inc. hannun jari shine yawan yawan ma'amaloli tare da hannun jari na MRSN da aka saya a lokacin da aka zaba.
04/05/2023 858 932 $
03/05/2023 14 597 076 $
02/05/2023 413 283 $
01/05/2023 1 702 185 $
28/04/2023 1 562 539 $
27/04/2023 90 724 $
26/04/2023 415 214 $

Mersana Therapeutics, Inc. capitalization daidai yake da 731 307 648 Dalar Amurka a 04/05/2023. Mersana Therapeutics, Inc. capitalization daidai yake da 699 132 288 Dalar Amurka a 03/05/2023. Mersana Therapeutics, Inc. capitalization kasuwa shine $ 471 341 664 a 02/05/2023. 01/05/2023 Mersana Therapeutics, Inc. capitalization kasuwa daidai yake da 508 802 464 dalar Amurka.

Babban tsarin kasuwancin Mersana Therapeutics, Inc. a 28/04/2023 wanda aka kimanta zuwa 469 913 088 dalar Amurka. Mersana Therapeutics, Inc. capitalization a 27/04/2023 sun kasance masu yawa 413 199 456 dalar Amurka. 26/04/2023 Mersana Therapeutics, Inc. karfaffen kaya ya kai 422 381 664 Dalar Amurka.

A capitalization na Mersana Therapeutics, Inc. a yau shi ne 731 307 648 $. Girman kasuwa na Mersana Therapeutics, Inc. ya canza zuwa +4.6% idan aka kwatanta da jiya. Hanyoyin ciniki na MRSN hannun jari na Mersana Therapeutics, Inc. a rana ta ƙarshe ta kasuwanci ya kasance 858 932 $. Ƙarin ciniki na Mersana Therapeutics, Inc. ya canza zuwa -94.116% idan aka kwatanta da ranar ciniki.

Kudin hannun jari Mersana Therapeutics, Inc.

Finance Mersana Therapeutics, Inc.